Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

MSLI 2.12 -0.04 (-1.85%)
price chart
Share Price of Merus Labs International Inc (USA) Rally 15.98%
Shares of Merus Labs International Inc (USA) (NASDAQ:MSLI) rose by 15.98% in the past week and 40% for the past 4 weeks.
Brokerage Firm Rating Disclosure Update on Merus Labs International Inc (USA)
Laurentian Bank initiates coverage on Merus Labs International Inc (USA) (NASDAQ:MSLI). In the latest research report, Laurentian Bank announces the target price to $3 per share on the counter.
Merus Labs International Inc. Completes $20 Million Bought Deal Financing
Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters") co-led by Cormark ...
Related articles »  
Merus Labs International Inc. Files SEC Form SC 13G, Statement of Acquisition ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Merus Labs International Inc. (Form SC ...
Merus Labs International Inc. Announces Completion of $7 Million Financing ...
14, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that, further to its news release dated July 4, 2014, the Company has today completed the financing acquisition transaction with Dacha ...
Related articles »  
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
8, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in certain European countries, the rights to ...
Merus Labs Acquire Sintrom from Novartis  Pharmaceutical Processing
Merus Labs International (T.MSL) subsidiary buys rights to anticoagulant ...  Stockhouse
Related articles »  
EmergingGrowth.com looks at Merus Labs International Inc. After Better than ...
May 28, 2013 (ACCESSWIRE via COMTEX) -- Merus Labs International Inc. MSLI, +0.93% (MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.
Related articles »  
Merus Labs International Inc. Announces Results for Fiscal 2014
TORONTO, ONTARIO, Dec 18, 2014 (Marketwired via COMTEX) -- Merus Labs International Inc. ("Merus" or the "Company") (MSL) MSLI, +19.57% is pleased to announce today its financial results for its fiscal year 2014.
Related articles »  
Merus Labs International Inc. Announces $22.1 Million Bought Deal Financing
TORONTO, June 11, 2014 /CNW/ - Merus Labs International Inc. ("the Company" or "Merus") [TSX: MSL] [NASDAQ: MSLI] is pleased to announce that it has entered into an agreement with a syndicate of investment dealers co-led by Canaccord Genuity Corp ...
Low share price no obstacle as Merus Labs, Madalena Energy raise equity  Financial Post
Related articles »